Side-by-side comparison of AI visibility scores, market position, and capabilities
Atlanta investment management (NYSE: IVZ) ~$1.85T AUM; QQQ ETF ($300B+ assets, world's most traded ETF), Q1 2025 EPS $0.44 (beat), $17.6B net inflows, 330bp margin expansion competing with BlackRock and Vanguard.
Invesco Ltd. is an Atlanta, Georgia-based global investment management company — publicly traded on the New York Stock Exchange (NYSE: IVZ) as an S&P 500 Financials component — managing approximately $1.85 trillion in assets under management across active equity, fixed income, multi-asset, and passive ETF strategies for institutional investors, financial advisors, and individual investors in more than 120 countries through approximately 8,400 employees. Invesco's most distinctive asset is the Invesco QQQ Trust (ticker: QQQ) — the world's most actively traded ETF, tracking the Nasdaq-100 index with $300B+ in assets and $100B+ in daily trading volume — which generates management fee revenue, brand recognition, and investor relationship access that no competitor outside BlackRock's iShares can match at that asset scale. In Q1 2025, Invesco reported earnings per share of $0.44 (beating analyst estimates of $0.40), revenue of $1.53 billion (beating expectations by $420 million), $17.6 billion in long-term net asset inflows representing 5.3% annualized growth, and adjusted operating margin expansion of more than 330 basis points year-over-year. CEO Andrew Schlossberg, who assumed leadership in 2023, has focused on operating efficiency and active ETF product development to compete with larger asset managers. Invesco acquired OppenheimerFunds from MassMutual in 2019 for $5.7 billion, expanding active equity capabilities and adding $228 billion in managed assets at the time.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.